Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer Part of the Evaluation Prognostic and Predictive Indicators in Head and Neck Cancer (EPIC) Programme, Run Under the Auspices of the Head and Neck Inter Group (HNCIG, Www.Hncig.Org)

NCT05936502 is registered in ClinicalTrials.gov with Head and Neck Cancer International Group as lead sponsor.

NCT NCT05936502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05936502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer Part of the Evaluation Prognostic and Predictive Indicators in Head and Neck Cancer (EPIC) Programme, Run Under the Auspices of the Head and Neck Inter Group (HNCIG, Www.Hncig.Org)
Lead sponsor
Head and Neck Cancer International Group
Phase
Observational
Overall status
Completed
Start date
July 11, 2022
Completion date
September 30, 2023
Enrollment
3,500 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

extranodal extension, head and neck squamous cell carcinoma, human papilloma virus related carcinoma